Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies | PLOS ONE
Structure of breast cancer resistance protein (BCRP). | Download Scientific Diagram
BCRP Probe Substrates - News - Solvo Biotechnology
![PDF] Diferencias interespecíficas y polimórficas en la actividad y modulación a través de inhibidores del transportador ABCG2/BCRP = Interspecific and polymorphic differences in the activity and modulation mediated by inhibitors of the](https://d3i71xaburhd42.cloudfront.net/67c009a799046711ed00bc1933d39e7a35f91d32/326-Figure1-1.png "PDF] Diferencias interespecíficas y polimórficas en la actividad y modulación a través de inhibidores del transportador ABCG2/BCRP = Interspecific and polymorphic differences in the activity and modulation mediated by inhibitors of the")
PDF] Diferencias interespecíficas y polimórficas en la actividad y modulación a través de inhibidores del transportador ABCG2/BCRP = Interspecific and polymorphic differences in the activity and modulation mediated by inhibitors of the
Interindividual Regulation of the Breast Cancer Resistance Protein/ABCG2 Transporter in Term Human Placentas | Drug Metabolism & Disposition
Schematic diagram of ABCG2/BCRP protein and its amino acid variations.... | Download Scientific Diagram
Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter | Journal of Pharmacology and Experimental Therapeutics
In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator‐activated receptor alpha (Pparα) at the blood–brain barrier - Hoque - 2015 - Journal of Neurochemistry - Wiley Online Library
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) | Oncogene
Structure of Breast Cancer Resistance Protein (BCRP)—this ABC... | Download Scientific Diagram
Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure | Drug Metabolism
IJMS | Free Full-Text | Characterization of a Potent, Selective, and Safe Inhibitor, Ac15(Az8)2, in Reversing Multidrug Resistance Mediated by Breast Cancer Resistance Protein (BCRP/ABCG2)
EFLUXX-ID® Gold multidrug resistance assay kit - ENZ-51030 - Enzo Life Sciences
Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
Caco-2 Intestinal Drug Transporter Models for More Predictive Drug Absorption
Molecules | Free Full-Text | Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP
Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling - ScienceDirect
Frontiers | Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
In Vitro and In Vivo Evaluation of ABCG2 (BCRP) Inhibitors Derived from Ko143 | Journal of Medicinal Chemistry
Efflux transporters at the blood-brain barrier These are mainly... | Download Scientific Diagram
Placental transporters | Faculty of Pharmacy - Research Portal
The Role of Intestinal Efflux Transporters In Drug Absorption
BCRP/ABCG2 Transporter Regulates Accumulation of Cadmium in Kidney Cells: Role of the Q141K Variant in Modulating Nephrotoxicity | Drug Metabolism & Disposition
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) | Oncogene
